PAR PHARM Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAR PHARM, and what generic alternatives to PAR PHARM drugs are available?
PAR PHARM has seventy-six approved drugs.
There is one US patent protecting PAR PHARM drugs. There are thirteen tentative approvals on PAR PHARM drugs.
There are nine patent family members on PAR PHARM drugs in eight countries and twenty-one supplementary protection certificates in eight countries.
Summary for PAR PHARM
| International Patents: | 9 |
| US Patents: | 1 |
| Tradenames: | 37 |
| Ingredients: | 37 |
| NDAs: | 76 |
| Patent Litigation for PAR PHARM: | See patent lawsuits for PAR PHARM |
| PTAB Cases with PAR PHARM as petitioner: | See PTAB cases with PAR PHARM as petitioner |
Drugs and US Patents for PAR PHARM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | HYDROXYZINE PAMOATE | hydroxyzine pamoate | CAPSULE;ORAL | 087658-001 | Jun 11, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Par Pharm | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 071600-001 | Oct 14, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Par Pharm | LORAZEPAM | lorazepam | TABLET;ORAL | 070677-001 | Dec 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Par Pharm | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 089422-001 | Jul 14, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Par Pharm | PROPANTHELINE BROMIDE | propantheline bromide | TABLET;ORAL | 088377-001 | Dec 8, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for PAR PHARM Drugs
Supplementary Protection Certificates for PAR PHARM Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1769785 | C300521 | Netherlands | ⤷ Sign Up | PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006 |
| 0383579 | C960030 | Netherlands | ⤷ Sign Up | PRODUCT NAME: REMIFENTANYLUM, DESGEWENST IN DE VORM VAN EEN ZUURADDITIE-ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 20601 - RVG 20603 19961015; 36335.00.00, 36335.01.00, 36335.02.00 19960517 |
| 0502314 | C300095 | Netherlands | ⤷ Sign Up | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
| 0836511 | CA 2006 00019 | Denmark | ⤷ Sign Up | PRODUCT NAME: FENTANYL HYDROCHLORID |
| 1635783 | C300653 | Netherlands | ⤷ Sign Up | PRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
